Feng Tian

This inventor holds 37 USPTO granted patents and 14 published patent applications, plus 11 CIPO patents and 16 EPO patents, primarily in Non-Natural Amino Acids. Top assignees: Ambrx, Inc., Eli Lilly and Company, Metabasis Therapeutics, Inc.. Active years: 2008-2026.

USPTO Granted Patents = 37 (Patent Applications = 14)

% Patents Active = 70.3

CIPO Patents = 11 (Patent Applications = 11)

EPO Patents = 16 (Patent Applications = 22)

Average Co-Inventor Count = 3.7

ph-index = 12

Forward Citations = 321(Granted Patents)

Location History:

Fairfax, VA (US) (2015 - 2019)
San Diego, CA (US) (2008 - 2023)
La Jolla, CA (US) (2024)

Company Filing History:

Eli Lilly and Company

patents

3 out of 64

Metabasis Therapeutics, Inc.

patents

4. 2 out of 1,203

Scripps Research Institute

where one patent can have more than one assignee

Years Active: 2008-2026

Loading Chart...

Areas of Expertise:

Non-Natural Amino Acids

Antibody Drug Conjugates

Polypeptide Modifications

Erythropoietin Polypeptides

Hybrid Suppressor tRNA

Glucokinase Activators

Posttranslational Modification

tRNA Compositions

Bioconjugates

Protein Production

Vaccines

Antigen-Binding Polypeptides

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12577575 - METHODS AND COMPOSITIONS FOR PROMOTING NON-NATURAL AMINO ACID-CONTAINING PROTEIN PRODUCTION (2026-03-17),

2. 12569566 - COMPOSITIONS CONTAINING, METHODS AND USES OF ANTIBODY-TLR AGONIST CONJUGATES (2026-03-10),

3. 12404512 - Method for optimizing antibody expression (2025-09-02),

4. 12377294 - Anti-CD3 antibody folate bioconjugates and their uses (2025-08-05),

5. 12059473 - Humanized anti-prostate -specific membrane antigen (PSMA) antibody drug conjugates (2024-08-13),

6. 12049485 - Interleukin-2 polypeptide conjugates and their uses (2024-07-30),

7. 11851662 - Methods and compositions for promoting non-natural amino acid-containing protein production (2023-12-26),

8. 11851488 - Anti-CD3-folate conjugates and their uses (2023-12-26),

9. 10800856 - Prostate-specific membrane antigen antibody drug conjugates (2020-10-13),

10. 10428333 - Non-natural amino acid replication-dependent microorganisms and vaccines (2019-10-01),

11. 10174062 - Activators of glucokinase (2019-01-08),

12. 9868972 - Hybrid suppressor tRNA for vertebrate cells (2018-01-16),

13. 9644014 - Modified animal erythropoietin polypeptides and their uses (2017-05-09),

14. 9522926 - Activators of glucokinase (2016-12-20),

15. 9488660 - Methods and compositions comprising non-natural amino acids (2016-11-08),

Title: The Innovative Journey of Feng Tian

Introduction: Feng Tian is a visionary inventor based in San Diego, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Feng Tian holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and creativity.

Career Highlights: With a background in engineering and a passion for solving complex problems, Feng Tian has led successful projects that have revolutionized industries and improved the lives of many.

Collaborations: Throughout his career, Feng Tian has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life and make a lasting impact on society.

Conclusion: Feng Tian's relentless pursuit of innovation and his dedication to pushing the boundaries of what is possible make him a true pioneer in the world of inventions.